Improving cancer and transplantation therapy through the development of new immunotherapeutic modalities. Projects include: Developing improved chimeric antigen receptors (CARs) for adoptive immunotherapy of cancer; Developing novel T cell stimulatory substrates based upon nano- and micro-fabricated surfaces for control of T cell proliferation and differentiation.
Principal Investigator: Michael C. Milone, MD, PhD